Unprecedented Data-Monitoring Backlogs And How To Deal With It

Recently, industry publications have filled with COVID-19-related clinical trial stories. As biotech and pharma companies the world over the race for a vaccine or a cure, there is another pandemic tale that is going unheralded: the virtual halt to real progress on clinical trials for anything except COVID-19. Though most fully halted trials were just in start-up mode, even trials that have maintained progress face dramatic delays. When operational, each study generates robust pools of data—yet clinical monitors can’t access the sites to conduct their traditional on-site point-by-point verification. Meanwhile, the data continues to pile up.

This webinar will focus on:

• Rapid Recovery Plan. What types of technology can be used to assess where the most significant risks lie in your study rapidly?
• Data Analysis. How the use of anomalous data and fraud detection methodologies can be used to support monitoring backlog recovery efforts.
• Lessons Learned. Applying the learnings from a rescue study to the current situation
• Future-Proofing your Monitoring Strategy: Assessing short term solution for long term gains